Pharmacokinetic mAb-mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts Publication Pharmacokinetic mAb-mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts To date, there has been little investigation of the risk for drug-drug interactions involving monoclonal…Certara2012年9月1日
Phenanthrene Metabolism in Smokers: Use of a Two-step Diagnostic Plot Approach to Identify Subjects with Extensive Metabolic Activation Publication Phenanthrene Metabolism in Smokers: Use of a Two-step Diagnostic Plot Approach to Identify Subjects with Extensive Metabolic Activation Polycyclic aromatic hydrocarbons (PAHs) in cigarette smoke are among the most likely causes of lung…Certara2012年9月1日
Armodafinil and Modafinil in Patients with Excessive Sleepiness Associated with Shift Work Disorder: A Pharmacokinetic and Pharmacodynamic Model for Predicting and Comparing Their Concentration-effect Relationships Publication Armodafinil and Modafinil in Patients with Excessive Sleepiness Associated with Shift Work Disorder: A Pharmacokinetic and Pharmacodynamic Model for Predicting and Comparing Their Concentration-effect Relationships Armodafinil, the longer lasting R-isomer of racemic modafinil, improves wakefulness in patients with excessive sleepiness…Certara2012年9月1日
Dealing with Excess of Zeros in the Statistical Analysis of Magnetic Resonance Imaging Lesion Count in Multiple Sclerosis Publication Dealing with Excess of Zeros in the Statistical Analysis of Magnetic Resonance Imaging Lesion Count in Multiple Sclerosis Lesion count observed on brain magnetic resonance imaging scan is a common end point in…Certara2012年9月1日
Dose Correction for the Michaelis-Menten Approximation of the Target—Mediated Drug Disposition Model Publication Dose Correction for the Michaelis-Menten Approximation of the Target—Mediated Drug Disposition Model The Michaelis-Menten (M-M) approximation of the target-mediated drug disposition (TMDD) pharmacokinetic (PK) model was derived…Certara2012年8月23日
The Right Compound in the Right Assay at the Right Time: An Integrated Discovery DMPK Strategy Publication The Right Compound in the Right Assay at the Right Time: An Integrated Discovery DMPK Strategy The high rate of attrition during drug development and its associated high research and development…Certara2012年8月1日
Saliva Versus Plasma Pharmacokinetics, Theory and Application of a Salivary Excretion Classification System Publication Saliva Versus Plasma Pharmacokinetics, Theory and Application of a Salivary Excretion Classification System The aims of this work were to study pharmacokinetics of randomly selected drugs in plasma…Certara2012年8月1日
Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone Effects on iNOS mRNA Expression and Nitric Oxide During LPS-induced Inflammation in Rats Publication Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone Effects on iNOS mRNA Expression and Nitric Oxide During LPS-induced Inflammation in Rats Increased expression of inducible nitric oxide synthase (iNOS) resulting in nitric oxide elevation represents an…Certara2012年8月1日
γ-hydroxybutyrate (GHB)-induced Respiratory Depression: Combined Receptor-transporter Inhibition Therapy for Treatment in GHB Overdose Publication γ-hydroxybutyrate (GHB)-induced Respiratory Depression: Combined Receptor-transporter Inhibition Therapy for Treatment in GHB Overdose Overdose of & γ;-hydroxybutyrate (GHB) frequently causes respiratory depression, occasionally resulting in death; however, little…Certara2012年8月1日
Impact of Low-dose Ritonavir on Danoprevir Pharmacokinetics: Results of Computer-based Simulations and a Clinical Drug-drug Interaction Study Publication Impact of Low-dose Ritonavir on Danoprevir Pharmacokinetics: Results of Computer-based Simulations and a Clinical Drug-drug Interaction Study Danoprevir, a potent, selective inhibitor of the hepatitis C virus (HCV) NS3/4A protease, is metabolized…Certara2012年7月1日